Home » Topics » Musculoskeletal, BioWorld Science

Musculoskeletal, BioWorld Science
RSS

INV-17 demonstrates safety and therapeutic activity in a model of rheumatoid arthritis

Nov. 17, 2014

R-Pharm CJSC discloses new B7 ligands/CD20 inhibitors

Nov. 4, 2014

Xencor regains rights to XmAb-5871

Oct. 29, 2014

Philogen begins phase II study of F8-IL10

Oct. 29, 2014

Ablynx reports results from subcutaneous ALX-0061 bioavailability study

Oct. 24, 2014

Phase III trials of secukinumab in ankylosing spondylitis meet primary endpoint

Oct. 23, 2014

FDA approves Xiaflex to treat up to two joints in Dupuytren's contracture

Oct. 21, 2014

Ampio Pharmaceuticals provides update on multiple-injection studies of Ampion

Oct. 20, 2014

Idera's IMO-9200 moves into phase I development

Oct. 16, 2014

Mochida and LG Life Sciences enter adalimumab biosimilar agreement

Oct. 15, 2014

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 25, 2026.
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...